Ironwood Pharmaceuticals Inc (NAS:IRWD)
$ 4.45 -0.14 (-3.05%) Market Cap: 712.13 Mil Enterprise Value: 1.26 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 54/100

Q4 2022 Ironwood Pharmaceuticals Inc Earnings Call Transcript

Feb 16, 2023 / 01:30PM GMT
Release Date Price: $11.35 (+1.34%)
Operator

Good day, and welcome to the Ironwood Pharmaceuticals Q4 and Full Year 2022 Investor Update Conference Call. Today's call is being recorded. (Operator Instructions) Thank you.

And I would now like to turn the conference over to Matt Roache, Director of Investor Relations. Please go ahead.

Matt Roache
Ironwood Pharmaceuticals, Inc. - Director of IR

Thank you, Savanna. Good morning, and thanks for joining us for our fourth quarter and full year 2022 investor update. Our press release issued this morning can be found on our website.

Today's call and accompanying slides include forward-looking statements. Such statements involve risks and uncertainties that may cause actual results to differ materially. A discussion of these statements and risk factors is available on the current safe harbor statement slide as well as under the heading, Risk Factors, in our annual report on Form 10-K for the year ended December 31, 2021, and in our future SEC filings. All forward-looking statements speak as of the day of this presentation, and we undertake no

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot